Holly Tao is a litigation associate in the Global Competition Group. Her practice focuses on complex litigation in the areas of antitrust, patent, and commercial contractual disputes, including litigation arising under the Biologics Price Competition and Innovation Act and the Hatch-Waxman Act. Holly has represented clients in the pharmaceutical, life sciences, and financial services industries in state and federal courts. Her practice also includes counseling major pharmaceutical clients on antitrust, patent, and intellectual property risk issues.
Holly is active in the firm's pro bono work, representing individuals and organizations in state administrative court and federal courts.
